H Keipp Talbot Selected Research

mRNA Vaccines

5/2022	Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
3/2022	Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
3/2022	The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
2/2022	Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
1/2022	Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
1/2022	Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
1/2022	Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
1/2022	mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
11/2021	The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
9/2021	Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Keipp Talbot Research Topics

Disease

65	Human Influenza (Influenza) 11/2022 - 05/2009
48	COVID-19 11/2022 - 09/2020
14	Infections 05/2022 - 03/2012
5	Frailty 01/2019 - 03/2012
3	Pneumonia (Pneumonitis) 11/2022 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
2	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2022 - 04/2021
2	Thrombosis (Thrombus) 01/2022 - 04/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 04/2021
2	Myocarditis (Carditis) 08/2021 - 07/2021
2	Virus Diseases (Viral Diseases) 11/2019 - 12/2017
1	Respiratory Insufficiency (Respiratory Failure) 03/2022
1	Guillain-Barre Syndrome 01/2022
1	Diabetes Mellitus 01/2022
1	Obesity 01/2022
1	Disease Progression 11/2021
1	Critical Illness (Critically Ill) 10/2021
1	Asymptomatic Infections 09/2021
1	Inflammation (Inflammations) 08/2021
1	Pericarditis 07/2021
1	Morbid Obesity 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Pneumococcal Infections 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Reinfection 11/2020
1	Chronic Disease (Chronic Diseases) 10/2020
1	Influenza in Birds (Avian Flu) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Heart Failure 01/2018
1	Myocardial Infarction 01/2018
1	Otitis Media 01/2017
1	Sinusitis 01/2017
1	Pharyngitis (Sore Throat) 01/2017
1	Pain (Aches) 01/2017
1	Colitis 01/2017
1	Invasive Fungal Infections 06/2016
1	Histoplasmosis 06/2016
1	Fever (Fevers) 01/2015
1	Vitamin D Deficiency 04/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2011

Drug/Important Bio-Agent (IBA)

61	VaccinesIBA 06/2022 - 12/2010
35	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2022 - 05/2009
19	COVID-19 VaccinesIBA 07/2022 - 11/2020
17	mRNA VaccinesIBA 05/2022 - 12/2020
10	BNT162 VaccineIBA 07/2022 - 12/2020
8	Antiviral Agents (Antivirals)IBA 11/2022 - 11/2012
7	Glycoproteins (Glycoprotein)IBA 03/2022 - 12/2020
7	Messenger RNA (mRNA)IBA 02/2022 - 07/2021
6	Lipid NanoparticlesIBA 03/2022 - 12/2020
6	NucleosidesIBA 03/2022 - 12/2020
5	2019-nCoV Vaccine mRNA-1273IBA 07/2022 - 01/2021
5	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 07/2010
5	AntibodiesIBA 01/2021 - 04/2015
5	AntigensIBA 01/2020 - 03/2010
3	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 04/2015
2	Dihydrotachysterol (AT 10)IBA 12/2021 - 10/2021
1	Viral RNAIBA 11/2022
1	cilgavimab and tixagevimab drug combinationIBA 07/2022
1	Aligeron (AS 2)IBA 07/2022
1	Neutralizing AntibodiesIBA 07/2022
1	COVID-19 vaccine booster shotIBA 11/2021
1	cyclo(Arg-Pro) (CI 4)IBA 10/2021
1	Immunoglobulin G (IgG)IBA 09/2021
1	Pharmaceutical PreparationsIBA 04/2021
1	Ad26COVS1IBA 04/2021
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2021
1	Conjugate VaccinesIBA 01/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2021
1	Coffee FDA Link 09/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	MF59 oil emulsionIBA 01/2020
1	aluminum sulfate (alum)IBA 01/2020
1	Respiratory Syncytial Virus VaccinesIBA 10/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 11/2016
1	Ribonuclease P (RNase P)IBA 11/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2016
1	Vitamin D FDA LinkGeneric 04/2013
1	CytokinesIBA 03/2012
1	Granzymes (Granzyme)IBA 03/2012
1	Interleukin-10 (Interleukin 10)IBA 03/2012
1	FlagellinIBA 12/2010
1	LigandsIBA 12/2010

Therapy/Procedure

9	Artificial Respiration (Mechanical Ventilation) 11/2022 - 09/2020
5	Long-Term Care 01/2021 - 12/2017
3	Therapeutics 10/2020 - 06/2016
2	Patient Readmission 01/2020 - 01/2020
2	Ambulatory Care (Outpatient Care) 01/2016 - 05/2009
1	Extracorporeal Membrane Oxygenation 02/2022
1	Enteral Nutrition (Feeding, Tube) 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Mechanical Ventilators (Ventilator) 12/2021
1	Length of Stay 12/2021
1	Contraindications 01/2021
1	Secondary Prevention 10/2020
1	Personal Protective Equipment 09/2020
1	Biological Therapy 01/2020
1	Hand Hygiene 12/2017
1	Institutionalization (Institutionalized Persons) 03/2011